Publications by authors named "James John Urbanic"
JAMA Oncol
September 2024
Article Synopsis
- A study was conducted to evaluate the impact of atezolizumab before and after chemoradiation therapy (CRT) in patients with unresectable stage III non-small cell lung cancer (NSCLC), showing promise in enhancing treatment outcomes.
- The trial involved 62 patients who received four cycles of atezolizumab, followed by CRT, with the primary measure being the disease control rate at 12 weeks.
- Results indicated improved disease control and safety patterns, suggesting pre-emptive use of atezolizumab could enhance patient responses to treatment.
